Cargando…
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
COVID-19, is a disease resulting from the SARS-CoV-2 global pandemic. Due to the current global emergency and the length of time required to develop specific antiviral agent(s) and a vaccine for SARS-CoV-2, the world health organization (WHO) adopted the strategy of repurposing existing medications...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354764/ https://www.ncbi.nlm.nih.gov/pubmed/32668312 http://dx.doi.org/10.1016/j.ejps.2020.105465 |